Skip to main content

Medipharm Labs Corp(LABS-T)
TSX

Today's Change
Real-Time Last Update

MediPharm Labs Settles an Outstanding Claim for $9M

PR Newswire - Mon Oct 2, 2023

TORONTO, Oct. 2, 2023 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a company specialized in precision-based cannabinoids, is pleased to announce it has entered into a settlement agreement on September 29, 2023 (the "Settlement Agreement") to resolve a claim in connection with a commercial agreement dispute, for a total consideration value of $9,000,000.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe